4D Molecular Therapeutics, Inc.

The current price of FDMT is 24.78 USD — it has decreased by 2.06% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 4D Molecular Therapeutics, Inc. stocks are traded under the ticker FDMT.

4D Molecular Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

FDMT stock is 2.39% volatile and has beta coefficient of 2.11. Check out the list of the most volatile stocks — is 4D Molecular Therapeutics, Inc. there?

One year price forecast for 4D Molecular Therapeutics, Inc. has a max estimate of 82.00 USD and a min estimate of 34.00 USD.

FDMT earnings for the last quarter are −0.24 USD per share, whereas the estimation was −0.61 USD resulting in a 60.86% surprise. The estimated earnings for the next quarter are −0.73 USD per share. See more details about 4D Molecular Therapeutics, Inc. earnings.

4D Molecular Therapeutics, Inc. revenue for the last quarter amounts to ‪20.20 M‬ USD despite the estimated figure of ‪8.07 M‬ USD. In the next quarter revenue is expected to reach ‪2.40 M‬ USD.

Yes, you can track 4D Molecular Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

FDMT net income for the last quarter is ‪−10.26 M‬ USD, while the quarter before that showed ‪−29.62 M‬ USD of net income which accounts for 65.37% change. Track more 4D Molecular Therapeutics, Inc. financial stats to get the full picture.

Today 4D Molecular Therapeutics, Inc. has the market capitalization of ‪1.27 B‬, it has increased by 2.75% over the last week.

No, FDMT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, FDMT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 4D Molecular Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

FDMT reached its all-time high on Feb 11, 2021 with the price of 55.11 USD, and its all-time low was 5.32 USD and was reached on Jun 16, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 147.00 employees. See our rating of the largest employees — is 4D Molecular Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 4D Molecular Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 4D Molecular Therapeutics, Inc. stock shows the buy signal. See more of 4D Molecular Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on 4D Molecular Therapeutics, Inc. future price: according to them, FDMT price has a max estimate of 82.00 USD and a min estimate of 34.00 USD. Read a more detailed 4D Molecular Therapeutics, Inc. forecast: see what analysts think of 4D Molecular Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 4D Molecular Therapeutics, Inc. EBITDA is ‪−99.31 M‬ USD, and current EBITDA margin is −516.90%. See more stats in 4D Molecular Therapeutics, Inc. financial statements.